Diabetic foot ulcers (DFU), one of the most serious complications of diabetes, are essentially
chronic, nonhealing wounds caused by diabetic neuropathy, vascular disease, and bacterial …

The emergence of nanotechnology has created unprecedented hopes for addressing
several unmet industrial and clinical issues, including the growing threat so‐termed …

The significant clinical challenge presented by diabetic wounds is due to their impaired
healing process and increased risk of complications. It is estimated that a foot ulcer will …

Chondroitin sulfate (CS), a natural anionic mucopolysaccharide, belonging to the
glycosaminoglycan family, acts as the primary element of the extracellular matrix (ECM) of …

Full-thickness wounds, lacking the epidermis and entire dermis and extending into
subcutaneous fat, represent a common treatment challenge. Due to the loss of adnexal …

Abstract Background Mesenchymal stem cells (MSCs)-based treatment strategy has shown
promise in bolstering the healing process of chronic wounds in diabetic patients, who are at …

Vasculogenic cell therapies have emerged as a powerful tool to increase vascularization
and promote tissue repair/regeneration. Current approaches to cell therapies, however, rely …

Prolonged inflammation and infection are the major factors that promote chronicity of the
wound. Despite the substantial advancements in therapeutic modalities, the treatment of …

Diabetes mellitus is a chronic disease characterized by metabolic dysregulation which is
frequently associated with diabetic foot ulcers that result from a severely compromised …

Sex hormones play a pivotal role in modulating various physiological processes, with
emerging evidence underscoring their influence on cancer progression and treatment …